Skip to main content

Table 1 Description of the study population (n = 305)

From: Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site

Demographics
Age, median years (IQR) 44.7 (37.4–51.0)
Caucasian ethnicity, n (%) 283 (92.8)
Clinical, HIV- and cART-related factors
Main route for HIV acquisition, n (%)  
 Homosexual/ Bisexual 262 (85.9)
 Heterosexual 27 (8.9)
 IVDU 4 (1.3)
 Other or unknown 12 (3.9)
cART, n (%) 289 (94.8)
Time on cART, median years (IQR) 4.4 (1.9–9.3)
HIV RNA, n (%)
 Not detected 221 (72.5)
 Detectable <40 copies/ml 47 (15.4)
  > 40 copies/ml 37 (12.1)
CD4+ cell count, n (%)
  ≥ 500/μl 243 (79.7)
 201–499/μl 54 (17.7)
  ≤ 200/μl 8 (2.6)
Patient-reported health behaviours
Cigarette smoking, n (%)
 Never 107 (35.1)
 Former 53 (17.4)
 Current 145 (47.5)
Use of recreational drug, n (%)
 Never 224 (73.4)
 Former 34 (11.1)
 Current 47 (15.4)
Current alcohol consumption (>3 units/daily), n (%) 11 (3.6)
Patient-reported sexual behaviours
Number of lifetime sexual partners, median (IQR)
 Heterosexual males 10 (5.5–35)
 Bi-sexual males 100 (30–300)
 Homosexual males 100 (20–400)
Receptive oral sex ever, n (%) 275 (90.2)
Sexual activity in previous 12 months, n (%) 284 (93.1)
Type of sexual partner in previous 12 months, n (%)a
 Heterosexual 31 (10.9)
 Bi-sexual 44 (15.5)
 Homosexual 209 (73.6)
Number of partners in previous 12 months, median (IQR)
 Heterosexual 1 (1–2)
 Bi-sexual 7 (3–19)
 Homosexual 4 (1–10)
Previous or current anal condylomatosis, n (%) 112 (36.7)
  1. cART: combination antiretroviral therapy; IVDU: intravenous drug use
  2. apercentages calculated on 284 sexually active men (93.1% of the total) in the last 12 months